Indhu Umapathi
Indhu Umapathi, University of Perpetual Help system DALTA, Philippines
Title: Furious Stem-Cell Technology To Cure Heart Cancer
Biography
Biography: Indhu Umapathi
Abstract
Statement of the problem: Cancer very seldom starts in the heart. But when it does, it can be deadly. An increased incidence of diagnosed primary cardiac tumours has been reported since the improvement of non-invasive imaging modalities. Heart cancer (primary cardiac tumour) arises in the heart which can be malignant and also benign. There are many types of tumour such as Lipoma, papillary fibroelastoma, rhabdomyoma etc.
Methodologies and theoretical observation: Cancerous (malignant) tumours that begin in the heart are most often sarcomas, a type of cancer that originates in the soft tissues of the body. Metastatic lesions are, by very definition, malignant in nature and are far more commonly encountered than primary tumors. Metastasis to the heart from other primary cancers is 30 times more common. Only 25% of primary cardiac tumors are malignant, and, of these, 75% are sarcomas.
Findings: To cardiologists, the stem-cell technology is a blockbuster discovery, since the heart has been pegged as a disadvantaged organ in terms of injury, healing, and repair.
Conclusion and significance: Scientists have known that adult stem cells can be found in the heart. This has prompted numerous centers in many countries to pursue stem cell therapeutics in patients with heart attacks, heart failure, and even severe angina to repair muscle and improve blood supply, which can also attempt to cure heart cancer in deciduous way. The work is moving fast and furiously to make it as a standard part of cardiac care.